{"nct_id":"NCT03251924","title":"A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors","status":"TERMINATED","status_verified_date":"2023-01","start_date":"2017-09-01","start_date_type":"ACTUAL","primary_completion_date":"2021-12-20","primary_completion_date_type":"ACTUAL","completion_date":"2021-12-20","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["BMY"]}